About Embecta Corp. 
Embecta Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 71 Schemes (50.14%)
Foreign Institutions
Held by 137 Foreign Institutions (8.25%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
264 Million
(Quarterly Results - Sep 2025)
Net Profit:
26 Million
Pharmaceuticals & Biotechnology
USD 730 Million (Small Cap)
6.00
NA
4.78%
-1.81
-999,999.00%
-1.12






